AR112333A1 - Pirrolopirimidina y derivados de pirrolopirimidina - Google Patents
Pirrolopirimidina y derivados de pirrolopirimidinaInfo
- Publication number
- AR112333A1 AR112333A1 ARP180101945A AR112333A1 AR 112333 A1 AR112333 A1 AR 112333A1 AR P180101945 A ARP180101945 A AR P180101945A AR 112333 A1 AR112333 A1 AR 112333A1
- Authority
- AR
- Argentina
- Prior art keywords
- pyrrolopyrimidine
- derivatives
- solvate
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Abstract
Reivindicación 1: Un compuesto de acuerdo con la fórmula (1), donde R¹ es H, CH₃, F o Cl; X es N, CH o C-CN; y R² es CH₃ o halógeno; o una sal farmacéuticamente aceptable, o un solvato, o una sal farmacéuticamente aceptable de un solvato de este; o un metabolito biológicamente activo de este.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1711234.3A GB201711234D0 (en) | 2017-07-12 | 2017-07-12 | Pyrrolopyrimidine and pyrrolopyridine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112333A1 true AR112333A1 (es) | 2019-10-16 |
Family
ID=59676761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180101945 AR112333A1 (es) | 2017-07-12 | 2018-07-12 | Pirrolopirimidina y derivados de pirrolopirimidina |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11136325B2 (es) |
| EP (1) | EP3652173A1 (es) |
| JP (1) | JP7198263B2 (es) |
| KR (1) | KR20200028436A (es) |
| CN (1) | CN111094283A (es) |
| AR (1) | AR112333A1 (es) |
| AU (1) | AU2018300218B2 (es) |
| BR (1) | BR112020000578A2 (es) |
| CA (1) | CA3069358A1 (es) |
| CO (1) | CO2020001346A2 (es) |
| GB (1) | GB201711234D0 (es) |
| IL (1) | IL271910B2 (es) |
| MX (1) | MX2020000005A (es) |
| PH (1) | PH12019502823A1 (es) |
| SG (1) | SG11202000168UA (es) |
| TW (1) | TWI794253B (es) |
| UY (1) | UY37809A (es) |
| WO (1) | WO2019012284A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201711234D0 (en) * | 2017-07-12 | 2017-08-23 | Galapagos Nv | Pyrrolopyrimidine and pyrrolopyridine derivatives |
| CN111303155A (zh) * | 2020-03-13 | 2020-06-19 | 深圳大学 | 靶向pak1抑制剂及其在抗肿瘤治疗药物中的应用 |
| CN111704617B (zh) * | 2020-06-15 | 2022-08-23 | 嘉兴特科罗生物科技有限公司 | 一种小分子化合物 |
| KR102635126B1 (ko) * | 2021-05-27 | 2024-02-13 | 한국과학기술연구원 | 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 피롤로피리미딘 유도체 및 이들의 용도 |
| CA3227277A1 (en) * | 2021-07-28 | 2023-02-02 | Sundeep Dugar | Pyrrolo[2,3-b]pyridine pgdh inhibitors and methods of making and using |
| WO2023014049A1 (ko) * | 2021-08-02 | 2023-02-09 | 한국화학연구원 | 신규한 피롤로 피리미딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 대사성 간질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100840727B1 (ko) | 1999-12-02 | 2008-06-23 | 오에스아이 파마슈티컬스, 인코포레이티드 | 아데노신 ａ1, ａ2ａ 및 ａ3 수용체 특이 화합물 및 그의 사용방법 |
| TW200306191A (en) * | 2002-02-22 | 2003-11-16 | Teijin Ltd | Pyrrolopyrimidine derivatives |
| AU2003284597A1 (en) | 2002-11-22 | 2004-06-18 | Takeda Pharmaceutical Company Limited | Apoptosis-associated protein and use thereof |
| EP2058309A4 (en) | 2006-08-04 | 2010-12-22 | Takeda Pharmaceutical | CONDENSED HETEROCYCLIC COMPOUND |
| CA2672373C (en) | 2006-12-19 | 2011-08-30 | Pfizer Products Inc. | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| WO2009027283A1 (en) | 2007-08-31 | 2009-03-05 | Merck Serono S.A. | Triazolopyridine compounds and their use as ask inhibitors |
| US8461163B2 (en) | 2008-03-31 | 2013-06-11 | Takeda Pharmaceutical Company Limited | Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1 |
| TWI598347B (zh) * | 2009-07-13 | 2017-09-11 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
| EP2651417B1 (en) * | 2010-12-16 | 2016-11-30 | Calchan Limited | Ask1 inhibiting pyrrolopyrimidine derivatives |
| GB201711234D0 (en) * | 2017-07-12 | 2017-08-23 | Galapagos Nv | Pyrrolopyrimidine and pyrrolopyridine derivatives |
-
2017
- 2017-07-12 GB GBGB1711234.3A patent/GB201711234D0/en not_active Ceased
-
2018
- 2018-07-12 TW TW107124084A patent/TWI794253B/zh active
- 2018-07-12 US US16/632,202 patent/US11136325B2/en active Active
- 2018-07-12 AR ARP180101945 patent/AR112333A1/es unknown
- 2018-07-12 AU AU2018300218A patent/AU2018300218B2/en not_active Ceased
- 2018-07-12 WO PCT/GB2018/051983 patent/WO2019012284A1/en unknown
- 2018-07-12 BR BR112020000578-9A patent/BR112020000578A2/pt unknown
- 2018-07-12 CA CA3069358A patent/CA3069358A1/en active Pending
- 2018-07-12 MX MX2020000005A patent/MX2020000005A/es unknown
- 2018-07-12 JP JP2020501447A patent/JP7198263B2/ja active Active
- 2018-07-12 EP EP18745683.5A patent/EP3652173A1/en active Pending
- 2018-07-12 UY UY0001037809A patent/UY37809A/es not_active Application Discontinuation
- 2018-07-12 CN CN201880045891.9A patent/CN111094283A/zh active Pending
- 2018-07-12 SG SG11202000168UA patent/SG11202000168UA/en unknown
- 2018-07-12 KR KR1020207004013A patent/KR20200028436A/ko not_active Application Discontinuation
-
2019
- 2019-12-13 PH PH12019502823A patent/PH12019502823A1/en unknown
-
2020
- 2020-01-08 IL IL271910A patent/IL271910B2/en unknown
- 2020-02-06 CO CONC2020/0001346A patent/CO2020001346A2/es unknown
-
2021
- 2021-09-03 US US17/466,230 patent/US20220169653A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019012284A1 (en) | 2019-01-17 |
| IL271910A (en) | 2020-02-27 |
| JP2020530833A (ja) | 2020-10-29 |
| AU2018300218B2 (en) | 2021-12-16 |
| BR112020000578A2 (pt) | 2020-07-14 |
| US20200165259A1 (en) | 2020-05-28 |
| TWI794253B (zh) | 2023-03-01 |
| AU2018300218A1 (en) | 2020-02-27 |
| RU2020106289A (ru) | 2021-08-12 |
| CA3069358A1 (en) | 2019-01-17 |
| PH12019502823A1 (en) | 2020-10-26 |
| GB201711234D0 (en) | 2017-08-23 |
| TW201908312A (zh) | 2019-03-01 |
| UY37809A (es) | 2019-02-28 |
| IL271910B1 (en) | 2023-03-01 |
| IL271910B2 (en) | 2023-07-01 |
| US11136325B2 (en) | 2021-10-05 |
| JP7198263B2 (ja) | 2022-12-28 |
| RU2020106289A3 (es) | 2021-11-10 |
| CN111094283A (zh) | 2020-05-01 |
| SG11202000168UA (en) | 2020-02-27 |
| EP3652173A1 (en) | 2020-05-20 |
| KR20200028436A (ko) | 2020-03-16 |
| MX2020000005A (es) | 2020-08-06 |
| US20220169653A1 (en) | 2022-06-02 |
| CO2020001346A2 (es) | 2020-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR112333A1 (es) | Pirrolopirimidina y derivados de pirrolopirimidina | |
| AR116604A1 (es) | Inhibidores de kras g12c | |
| CY1119771T1 (el) | Ενωσεις αμινοπυριμιδινυλιου ως αναστολεις toy jak | |
| AR109349A1 (es) | Compuestos y usos | |
| PH12020551616A1 (en) | N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof | |
| AR105238A1 (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso | |
| AR115949A1 (es) | Compuestos heterocíclicos | |
| AR101367A1 (es) | Pirimidinonas como inhibidores del factor xia | |
| AR111315A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
| EA202092263A1 (ru) | Аминопиридиновые производные в качестве ингибиторов ctps1 | |
| AR117189A1 (es) | Derivados de 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activos contra el virus de la hepatitis b (vhb) | |
| EA202191104A1 (ru) | Производные аминопиридина/пиразина в качестве ингибиторов ctps1 | |
| AR103412A1 (es) | Derivados de indol mono o disustituido como inhibidores de la replicación del virus del dengue | |
| AR103170A1 (es) | Compuestos y composiciones farmacéuticas de los mismos para el tratamiento de desordenes inflamatorios y osteoartritis | |
| EA201692266A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| CY1125004T1 (el) | Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας | |
| EA201690072A1 (ru) | Состав, содержащий гиполипидемическое средство | |
| AR111806A1 (es) | Derivados de indol n-sustituidos | |
| AR117920A1 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| EA201791667A1 (ru) | Соединения бензоксаборола и их применение | |
| AR116947A1 (es) | Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb) | |
| AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
| CY1125355T1 (el) | Πεντακυκλικη ενωση | |
| NI201800063A (es) | Compuesto de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer |